Clinical effect of metoprolol combined with trimetazidine in the treatment of coronary heart disease with heart failure

doi:10.3877/cma.j.issn.2095-6568.2018.02.015

Abstract

Abstract:

Objective

To investigate clinical effect of metoprolol combined with trimetazidine in the treatment of coronary heart disease with heart failure.

Methods

Eighty patients with CHF treated in Jieshou People's Hospital from July of 2016 to June of 2017 were divided into control group and experimental group according to the treatment methods. The control group received routine treatment, while the experimental group received metoprolol and trimetazidine on this basis. The therapeutic effects of the two groups were compared.

Results

The total effective rate of experimental group was 92.5%, higher than that of control group (75.0%), and there was significant difference between the two groups (P<0.05). After treatment, LVESD, LVEF and LVEDD of experimental group were better than those of control group (P<0.05).

Conclusion

Metoprolol combined with trimetazidine has a significant effect in the treatment of coronary heart disease with heart failure, can effectively improve the cardiac function of patients, is worthy of clinical promotion.

Key words: Heart failure, Coronary heart disease, Trimetazidine, Metoprolol

JinYing Zhao. Clinical effect of metoprolol combined with trimetazidine in the treatment of coronary heart disease with heart failure[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2018, 06(02): 109-111.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxzyxldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-6568.2018.02.015

https://zhxzyxldzzz.cma-cmc.com.cn/EN/Y2018/V06/I02/109

Figures/Tables 2

References 11

[1]	郭继芳，游陆，李作武. 美托洛尔联合曲美他嗪治疗冠心病心力衰竭的疗效及对血浆脑钠肽水平的影响[J]. 中国医院用药评价与分析，2017, 17(8)：1047-1048, 1051.
[2]	杨会萍，任骞. 美托洛尔联合曲美他嗪对冠心病心力衰竭患者炎性反应、T细胞亚群及心功能的影响研究[J]. 实用心脑肺血管病杂志，2016, 24(8)：20-23.
[3]	王象勇，赵远，罗梦琳. 曲美他嗪与美托洛尔联合应用对冠心病心力衰竭炎症因子及心功能的影响[J]. 国际检验医学杂志，2017, 38(22)：3193-3196.
[4]	姚朝阳. 麝香保心丸联合美托洛尔及曲美他嗪治疗冠心病心力衰竭的临床研究[J]. 中西医结合心脑血管病杂志，2016, 14(6)：615-617.
[5]	王国立. 观察美托洛尔联合曲美他嗪治疗冠心病心力衰竭患者的临床疗效[J]. 中国医药指南，2016, 12(18)：533-534.
[6]	刘永东，高亢. 阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效[J]. 中国循证心血管医学杂志，2016, 8(3)：370-371.
[7]	尚永志. 阿托伐他汀联合曲美他嗪治疗冠心病的效果观察[J]. 中国现代药物应用，2015, 26(22)：1988-1989.
[8]	刘青山，钟伟州. 盐酸曲美他嗪治疗冠心病稳定型心绞痛的效果观察[J]. 中国医学创新，2015, 12(14)：52-54.
[9]	程正红. 美托洛尔联合曲美他嗪治疗冠心病心力衰竭的临床价值研究[J]. 当代医学，2017, 23(25)：103-105.
[10]	袁磊. 美托洛尔联合曲美他嗪治疗冠心病心力衰竭的临床疗效观察[J]. 中国现代医生，2016, 54(35)：100-102.
[11]	王学影. 曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭患者的临床效果[J]. 中国医药导报，2017, 14(2)：131-134.

组别	n	显效	有效	无效	总有效率
对照组	40	15	15	10	75.0
实验组	40	17	20	3	92.5
χ²值	?	?	?	?	4.501
P值	?	?	?	?	0.034

组别	n	显效	有效	无效	总有效率
对照组	40	15	15	10	75.0
实验组	40	17	20	3	92.5
χ²值	?	?	?	?	4.501
P值	?	?	?	?	0.034

组别	n	LVEF(%)		LVESD(mm)		LVEDD(mm)
组别	n	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
对照组	40	41.7±6.4	45.8±7.2^a	41.3±6.6	36.6±4.9^a	64.2±8.3	60.4±6.6^a
实验组	40	41.4±6.8	51.9±7.5^ab	41.2±6.4	32.8±5.4^ab	64.1±8.9	51.8±6.5^ab

组别	n	LVEF(%)		LVESD(mm)		LVEDD(mm)
组别	n	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
对照组	40	41.7±6.4	45.8±7.2^a	41.3±6.6	36.6±4.9^a	64.2±8.3	60.4±6.6^a
实验组	40	41.4±6.8	51.9±7.5^ab	41.2±6.4	32.8±5.4^ab	64.1±8.9	51.8±6.5^ab

[1]	Ying Li, Shaoqing Pan, Mingyan Ding, Dandan Sun, Haibo Qu, Peipei Hou, Fang Zhu. Evaluation of left ventricular systolic function and synchrony in advanced atrioventricular block patients with heart failure with preserved ejection fraction after left bundle branch area pacing by real-time three-dimensional echocardiography [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(04): 430-436.
[2]	Yifan Liu, Di Gao, Jia Dong, Kaiyuan Zhu, Xin Pan, Fenglei Zhang, Dachun Xu, Chunxi Yan. Prognostic value of soluble suppression of tumorigenicity-2 in hospitalized patients with acute heart failure [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2023, 16(01): 13-19.
[3]	Xuefeng Sun. RAAS inhibitors in the treatment of patients with chronic kidney disease accompanied by heart failure [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(06): 301-306.
[4]	Linyang Yu, Meiying Wang, Jianbin Li, Xiaobin Lou, Siyuan Xie, Zhizhong Ma, Haiying Qi, Jia Li. Characteristics of pulmonary arterial pressure and cardiac morphology and function in children with pneumonia and right heart failure in a high altitude area [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 535-544.
[5]	Zhen Wang, Xiaoyue Yang, Kangkang Su, Chaoyang Wang, Shaojie Li, Shuxia Chen, Jian Gu. Progress in understanding of prognostic impact of beta-blockers on patients with heart failure and atrial fibrillation [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 479-482.
[6]	Zhiming Wang, Yueqing Huang, Qinghua Ma, Weihai Chen, Qin Sun, Renlin Yin, Yanming Wu, Fulong Ye, Hua You, Min Huang. Application of "specialty-general practice" integrated management in elderly patients with non-valvular atrial fibrillation and heart failure: a propensity score matching study [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1188-1193.
[7]	Jie Chen, Feng Zhou, Jinbo Liu, Hongyu Wang. Drug therapy pattern and population heterogeneity of patients with coronary heart disease based on cluster analysis [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(10): 1012-1018.
[8]	Mingxue Li, Zimo Li, Jianli Tian. Relationship between blood pressure and heart failure: research status and challenges [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(08): 805-809.
[9]	Hongyan Tang, Haijun Dan, Zhihong Gao, Zuoyang Zhang, Shumei Zhai, Shaoyu Wu, Yu Zhang. Specificity and sensitivity of cardiac color Doppler ultrasound in clinical diagnosis of patients with chronic heart failure [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(07): 676-679.
[10]	Weiwei Zong, Dongmei Xu, Xinyue Zhang, Jie Geng. Effect of integrated medical and nursing management mode on medication compliance and complications in elderly patients with heart failure treated with sacubitril/valsartan [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(06): 588-592.
[11]	Qi Cai, Yonghong Yong, Hua He, Tongsheng She, Hui Yu. Evaluation of left ventricular function in patients with coronary heart disease by three-dimensional speckle tracking imaging combined with serum homocysteine [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(05): 425-430.
[12]	Yicheng Guo, Zhipeng Xie, Wanli Liu, Yang Zhao, Yansheng Che, Min Zhao. Characteristic analysis of precordial referred pain caused by osteoporotic vertebral compression fracture in the 12th thoracic vertebrae misdiagnosed as coronary heart disease [J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(02): 136-139.
[13]	Chenglin Zhang, Xuemei Li, Huixin Wu, Xiaoyan Li. Construction of nursing quality evaluation index system of volume management in patients with heart failure [J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2023, 11(03): 173-178.
[14]	Qianwen Kong, Shan Liu, Caihong Zeng, Qingchun Zeng. Observational study of the effects of aerobic and resistance exercise on heart rate variability in patients with heart failure [J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2023, 11(03): 160-164.
[15]	Shaohua Guo, Shijia Geng, Shenda Hong, Guanyu Mu, Yizhi Zhang, Lei Yang, Tong Liu, Kangyin Chen. Use of an artificial intelligence-enabled electrocardiogram for screening people without coronary heart disease [J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2023, 11(01): 18-23.

Please choose a citation manager

Content to export